» Articles » PMID: 24506683

Tumor-homing Glycol Chitosan-based Optical/PET Dual Imaging Nanoprobe for Cancer Diagnosis

Overview
Journal Bioconjug Chem
Specialty Biochemistry
Date 2014 Feb 11
PMID 24506683
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Imaging techniques including computed tomography, magnetic resonance imaging, and positron emission tomography (PET) offer many potential benefits to diagnosis and treatment of cancers. Each method has its own strong and weak points. Therefore, multimodal imaging techniques have been highlighted as an alternative method for overcoming the limitations of each respective imaging method. In this study, we fabricated PET/optical activatable imaging probe based on glycol chitosan nanoparticles (CNPs) for multimodal imaging. To prepare the dual PET/optical probes based on CNPs, both (64)Cu radiolabeled DOTA complex and activatable matrix metalloproteinase (MMP)-sensitive peptide were chemically conjugated onto azide-functionalized CNPs via bio-orthogonal click chemistry, which was a reaction between azide group and dibenzyl cyclooctyne. The PET/optical activatable imaging probes were visualized by PET and optical imaging system. Biodistribution of probes and activity of MMP were successfully measured in tumor-bearing mice.

Citing Articles

Click Chemistry and Radiochemistry: An Update.

Bauer D, Cornejo M, Hoang T, Lewis J, Zeglis B Bioconjug Chem. 2023; 34(11):1925-1950.

PMID: 37737084 PMC: 10655046. DOI: 10.1021/acs.bioconjchem.3c00286.


Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents.

Kubeil M, Suzuki Y, Casulli M, Kamal R, Hashimoto T, Bachmann M Adv Healthc Mater. 2023; 13(1):e2301404.

PMID: 37717209 PMC: 11468994. DOI: 10.1002/adhm.202301404.


All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy.

Song S, Shim M, Yang S, Lee J, Yun W, Cho H Bioact Mater. 2023; 28:358-375.

PMID: 37334068 PMC: 10276196. DOI: 10.1016/j.bioactmat.2023.05.016.


Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment.

Gonzalez-Avila G, Sommer B, Garcia-Hernandez A, Ramos C, Flores-Soto E Front Mol Biosci. 2022; 9:918789.

PMID: 35720130 PMC: 9198274. DOI: 10.3389/fmolb.2022.918789.


The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy.

Vizovisek M, Ristanovic D, Menghini S, Christiansen M, Schuerle S Int J Mol Sci. 2021; 22(5).

PMID: 33802262 PMC: 7958950. DOI: 10.3390/ijms22052514.